Document is current

Any future updates will be listed below

Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

Crossref DOI link: https://doi.org/10.1186/s13063-023-07364-3

Published Online: 2023-05-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark